ABSTRACT
Este é um relato de caso com discussão dos desfechos materno-fetais de gestantes com transposição de grandes vasos congenitamente corrigida (TGVCC). Gestante com transposição de grandes artérias congenitamente corrigida TGACC, internada com 35 semanas de gestação por dispneia e cianose central, evoluindo para parto vaginal com fórcipe e recebendo alta com recém-nascido clinicamente estável. A mesma paciente é internada novamente após 1 ano, gestante e com as mesmas queixas, apresentando dor precordial no trabalho de parto. Foi indicada cesárea por desproporção cefalopélvica. Teve alta clinicamente estável. Os recém-nascidos não apresentaram malformações cardíacas. Em conclusão, gestantes portadoras de TGACC devem receber atenção multidisciplinar diferenciada devido à gestação de alto risco, tendo indicação de parto normal assistido e monitorado, visando diminuir a morbimortalidade materna.
Case report and discussion of maternal-fetal outcomes in pregnant patients with congenitally corrected transposition of the great vessels (CCTGV). A pregnant woman with CCTGV was hospitalized at 35 weeks of gestation for dyspnea and central cyanosis. Her baby was born via forceps delivery and was clinically stable when discharged from hospital. The patient returned to the hospital 1 year later. She was pregnant and presented the same complaints, with precordial pain during labor. Cesarean delivery was indicated due to dystocia. She was clinically stable when discharged from hospital. Both newborns did not have cardiac malformations. Pregnant patients suffering from CCTGV should receive multidisciplinary attention due to the high-risk pregnancy, with recommendation of assisted and monitored vaginal labor to reduce maternal morbidity and mortality.
Subject(s)
Humans , Pregnancy , Adult , Prenatal Care , Parturition , Transposition of Great Vessels/complications , Transposition of Great Vessels/diagnosis , Transposition of Great Vessels/genetics , Transposition of Great Vessels/pathology , Cyanosis/complications , Cyanosis/diagnosis , Dyspnea/complications , Dyspnea/diagnosis , Heart Diseases , Pregnancy, High-RiskABSTRACT
Beta1-adrenergic receptor polymorphisms have been implicated with inconsistent results in the pathogenesis, clinical presentation, and prognosis of patients with heart failure (HF). The impact of 2 functional polymorphisms (beta1-Arg389Gly and beta1-Ser49Gly) on HF susceptibility, arrhythmogenesis, and prognosis was evaluated in Brazilian outpatients. Genotyping at codons 389 and 49 was performed using polymerase chain reaction with restriction fragment length polymorphism analysis in 201 outpatients with systolic HF and 141 apparently healthy controls. Enrolled patients were followed up at the HF clinic, and vital status was evaluated using electronic hospital records, telephone contact, and a local death certificate database. Allele frequencies were similar between patients with HF and controls, with neither polymorphism related to HF susceptibility. The beta1-389Gly homozygotes had significantly less nonsustained ventricular tachycardia on Holter monitoring (17% vs 48% for Arg/Arg patients; p = 0.015) and improved HF-related survival, with no events after a median follow-up of 40 months (log-rank statistics = 0.025). The negative impact of beta1-389Arg allele on HF-related survival was substantially reduced using high-dose beta-blocker therapy (80% survival for high-dose vs 42% for low-dose beta blockers or nonusers; log-rank statistics = 0.0003). The beta1-Ser49Gly polymorphism was not associated with nonsustained ventricular tachycardia or HF prognosis. In conclusion, beta1-Arg389Gly and beta1-Ser49Gly polymorphisms had no influence on HF susceptibility. However, the Gly389 allele was associated with a lower prevalence of ventricular arrhythmias and better HF-related survival. A pharmacogenetic interaction is suggested because beta blockers were more effective in beta1-389Arg allele carriers.
